Clinical Trial Update: Effects of Finerenone on Vascular Stiffness and Cardiorenal Biomarkers in T2D and CKD (FIVE-STAR) [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating finerenone effects on vascular stiffness and cardiorenal biomarkers in type 2 diabetes with chronic kidney disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• Finerenone (finerenone)

Snippet

Sponsor: Saga University | Conditions: Type 2 Diabetes, Chronic Kidney Diseases | Phase 4 | Status: ACTIVE_NOT_RECRUITING